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Concomitant use of pharmacologic agents may be re-
quired for maximal salvage of ischemic myocardium by
reperfusion. Accordingly, in dogs with induced throm-
botic coronary occlusion, the effects of intravenous dil-
tiazem given 30 minutes before administration of strep-
tokinase on myocardial bloodflow and myocardial salvage
were evaluated. Two independent types of end points
were employed. Positron emission tomography was uti-
lized for noninvasive assessment of myocardial perfusion
and infarct extent. Direct measurements included quan-
tification of myocardial infarction by assay of creatine
kinase activity in myocardial homogenates. Infarct ex-
tent averaged 27.9 ± 11.4% of left ventricular weight
in 10control dogs in which coronary occlusion was main-
tained for 24 hours. In eight dogs given streptokinase
alone, the infarct extent averaged 16.7 ± 10.0% of left
ventricular mass (p < 0.05 versus control). In nine other
dogs given diltiazem (15 ILg/kg per min continuously
until death was induced) beginning 30 minutes before
streptokinase, infarct extent averaged 9.4 ± 6.7% of
left ventricular mass (p < 0.05 compared with reper-
Coronary thrombolysis is a promising means for salvaging
ischemic myocardium. Results from experimental animals
have documented salvage and suggested that it may be fa-
cilitated by concomitant administration of pharmacologic
agents (I). Calcium channel blockers offer particular prom-
ise because of the potentially deleterious effects of intra-
cellular influx of calcium that accompanies reperfusion. Fur-
thermore, they appear to exert beneficial effects on the
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fusion alone). At the dose administered, diltiazem did
not alter blood flow, heart rate or mean arterial pressure
after coronary occlusion or thrombolysis.
The region at risk, determined in 16 dogs from per-
fusion images obtained with positron tomography and
oxygen-IS-labeled water after coronary occlusion, was
similar in the three groups (30.6 ± 7.3% of the left
ventricle in six control dogs, 31.8 ± 4.5% in five dogs
with reperfusion alone and 30.5 ± 11.6% in five dogs
with reperfusion plus diltiazem). Infarct size quantified
in terms of the extent of myocardium exhibiting less than
50% of peak carbon-II-labeled palmitate uptake 24 hours
after occlusion and expressed as the percent of the region
at risk averaged 89.6 ± 11.4% in control dogs, was
significantly reduced to 45.1 ± 29.8% in dogs with re-
perfusion alone and was reduced further to 22.3 ± 16.4%
in dogs given diltiazem and reperfusion. Thus, concom-
itant treatment with diltiazem markedly enhances sal-
vage of reperfused myocardium after coronary
thrombolysis.
(J Am Coli CardioI1986;8:861-71)
mechanical function of myocardium subjected to ischemia
followed by reperfusion (2,3).
One of the difficulties encountered in determining whether
adjunctive pharmacologic approaches are beneficial is that
of quantifying the extent of infarction in the setting of re-
perfusion. Despite the availability of methods for assessing
infarct size at necropsy, determination of the infarct extent
with conventional techniques in vivo is subject to error.
Positron emission tomography permits noninvasive esti-
mation of myocardial perfusion and metabolism and se-
quential delineation of myocardium at risk. It has been uti-
lized for evaluation of interventions designed to limit
myocardial damage (4). However, to avoid ambiguous inter-
pretation, results should be referenced to direct measure-
ments under comparable conditions.
The present study was undertaken to determine whether
calcium channel blockade with diltiazem enhances salvage
of myocardium by reperfusion in dogs with thrombotic coro-
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nary occlusion and in which coronary thrombolysis is in-
duced by streptokinase . Direct end points included assess-
ment of myocardial creatine kinase depletion and delineation
of the distribution of radiolabeled microspheres in myocar-
dium. Positron emission tomography was employed to de-
fine the extent of myocardium undergoing infarction that
could be characterized noninvasively and to evaluate se-
quential changes in risk region and the extent of apparent
injury. Correlative studies were undertaken to determine
whether the effects of the pharmacologic intervention cou-
pled with reperfusion would distort relation between to-
mographically measured perfusion and perfusion measured
directly and between tomographically estimated injury and
infarct size measured directly . The results obtained indicate
that diltiazem enhances salvage of myocardium subjected
to reperfusion .
Methods
Animal preparations. Dogs of either gender were fasted
overnight, premedicated with subcutaneous morphine sul-
fate (I mg/kg body weight) and anesthetized with intrave-
nous sodium pentothal (12.5 mg/kg) and alpha-chloralose
(60 mg/kg). After endotracheal intubation, ventilation was
maintained with room air using a Harvard respirator. An
intravenous catheter was placed in a peripheral vein for
infusion of drugs . Catheters were placed in the abdominal
aorta and vena cava through the femoral artery and vein . A
left atrial catheter was introduced through the other femoral
artery and advanced across the aortic and mitral valves under
fluoroscopic guidance. A modified Amplatz catheter was
inserted into the left common carotid artery.
Arterial pressure and the electrocardiogram were moni-
tored and recorded with a Gould two-channel recorder. Be-
fore induction of coronary occlusion, a loading dose of
lidocaine, 1 mg/kg, was given intravenously, followed by
a continuous infusion of 50 j.tg/kg per min.
Coronary thrombosis was induced as described previ-
ously (4). After initial coronary arteriography had been per-
formed, a 0.021 inch (0.053 cm) guide wire was advanced
into the left anterior descending coronary artery and the
coronary catheter was withdrawn. A copper coil (diameter
3 mm, length 5 mm) was advanced over the guide wire with
a small (diameter 1.2 mm) flexible catheter until the coil
lodged in the left anterior descending coronary artery. The
guide wire was removed and the small intracoronary catheter
was positioned approximately I em proximal to the coil.
This catheter was used for injections of contrast medium
and for intracoronary administration of streptokinase.
To verify complete occlusion of the left anterior descend-
ing coronary artery by thrombus at the site of the coil.
angiography was repeated after ST segment elevation had
developed. In animals given streptokinase, angiography was
repeated to document restoration of patency of the artery.
The coil was then removed by pulling a fine suture to which
it had been attached. Thus, reperfusion was maintairted without
the need for heparinization .
In animals to be given diltiazem, a polyvinyl! catheter
was inserted in the left external jugular vein, tunneled be-
neath the skin and exteriorized between the scapulae.' Sus-
tained infusion of diltiazem was accomplished with the use
of a portable infusion pump (Auto-Syringe, Inc .),' The other
catheters were removed, incisions were closed and the an-
imals were allowed to recover from anesthesia.
Ventricular myocardial samples. On the next day, ani-
mals were anesthetized again and coronary angiography was
repeated to confirm the persistence of occlusion in control
dogs and the persistence of patency of the left anterior de-
scending coronary artery in dogs given streptokinase. Twenty-
four hours after coronary occlusion, cardiac arrest was in-
duced with an overdose of saturated potassium. chloride
given intravenously . The heart was removed rapidly and
rinsed promptly in saline solution at 0 to 4°C. The left
anterior descending artery and its branches were examined
to determine whether thrombus was present and to detect
any signs of trauma from manipulation ofcatheters. Samples
of left ventricular myocardium were obtained for assay of
radioactivity associated with microspheres. Tissue samples
were obtained for assay of myocardial creatine kinase and
protein in normal myocardium from the posterior left ven-
tricle and from homogenates of the remainder of the left
ventricle.
Experimental protocols. Three groups of dogs were
studied . In 15 control dogs, occlusion of the left anterior
descending coronary artery was maintained for 24 hours.
Thrombolytic agents were not given and the copper coil was
left in place until the heart was excised . In the other two
groups, comprising 26 dogs, intracoronary streptokinase
(4,000 Il.l/rnin for 90 minutes) was administered beginning
2 hours after coronary occlusion . Thirteen of the dogs were
not given diltiazem. They constituted the "reperfusion alone"
group . The other 13 dogs were given diltiazem (generously
supplied by Marion Laboratories, Inc.) intravenously at a
dose of 15 j.tg/kg per min beginning 90 minutes after coro-
nary occlusion, that is, 30 minutes before the onset of in-
fusion of streptokinase. The infusion of diltiazem was con-
tinued until the heart was excised. The dose of diltiazem
was selected to minimize alterations of heart rate or blood
pressure and to be sufficient for effective calcium channel
blockade .
For assessment ofmyocardial bloodfiow and myocardial
viability. two types of experiments were performed. Effects
of thrombolysis with or without diltiazem on myocardial
blood flow and infarct extent were determined with the use
of radiolabeled microspheres injected into the left atrium ,
and by direct assay of radioactivity in myocardial samples
and direct analysis of myocardial creatine kinase depletion
at necropsy. In other experiments, effects of thrombolysis
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with or without diltiazem on myocardial blood flow and
metabolism were assessed sequentially by positron emission
tomography with oxygen-IS-labeled water and carbon-
l I-Iabeled palmitate, respectively. In these experiments,
regional myocardial blood flow was quantified with radio-
labeled microspheres as well. Some dogs were evaluated
according to both protocols.
Dogs that developed ventricular fibrillation after coro-
nary occlusion or reperfusion and those that did not survive
for 24 hours were excluded. The number of animals ex-
cluded from the two groups subjected to reperfusion (with
and without diltiazem) was the same, that is, 11 from each
group. These dogs did not have perfusion data different
from dogs that survived. Animals with no region of myo-
cardium after coronary occlusion exhibiting a flow of less
than 25% of that in normal regions (measured with micro-
spheres) were excluded (n = 8) because of the lack of a
substantial region at risk.
Myocardial blood flow. Regional myocardial blood flow
was measured with 15 JL radiolabeled microspheres accord-
ing to the standard reference withdrawal method (5). For
each determination of flow, 3 to 4 million microspheres
labeled with cesium-I4, chromium-51, tin-Ill, strontium-
85 or scandium-46 were injected into the left atrium. Flow
was determined throughout three 1 to 1.5 em thick sections
of myocardium. Each was divided into central, lateral and
septal ischemic zones and one posterior normal region. Sam-
ples were trimmed of epicardial fat and connective tissue
and subdivided into endocardial and epicardial layers.
Flow was determined in some animals before induction
of ischemia and in all animals 60 to 90 minutes after oc-
clusion of the left anterior descending coronary artery and
again 24 hours after occlusion. Microspheres were injected
1 hour after reperfusion in dogs given streptokinase.
Determination of infarct size. The extent of myocardial
infarction was determined at necropsy by assay of creatine
kinase activity in left ventricular homogenates as described
previously (6). Tissue samples used for analysis of the dis-
tribution of microspheres were kept frozen throughout the
procedure for assay of radioactivity and added to the re-
mainder of the heart before homogenization for assay of
total creatine kinase activity. Total creatine kinase per gram
of left ventricle was compared with creatine kinase per gram
in normal myocardium from the posterobasalleft ventricular
wall for calculation of infarct size expressed as a percent
of left ventricular weight.
Positron emission tomography. Sixteen dogs were
evaluated by positronemission tomography. They were placed
within a plexiglass shell positioned within a tomograph (PETT
VI) such that the entire left ventricle was within the field
of view. Data acquisition was performed in high resolution
mode (full width at half maximum = 0.7 em) with simul-
taneous acquisition of data from seven transverse sections
with a separation between slices of 1.4 em (7). Emission
scans were corrected for attenuation with transmission data
acquired with an external ring source of germanium-68.
Myocardial perfusion and metabolism were assessed with
oxygen-IS-labeled water (HZ I 50) and carbon-Ll-Iabeled
palmitate eIC-palmitate) respectively.
For each determination of the distribution ofmyocardial
blood flow, 45 to 55 mCi of HZ150 in saline solution was
injected intravenously as a bolus. Six consecutive 10 second
images were collected beginning at the time of injection.
Data collection in the interval from 10 to 50 seconds after
injection was used for determination of relative tissue myo-
cardial blood flow. Approximately 10 minutes later, when
activity from HZ I 50 (half-life = 2.1 minutes) had decayed
to near background levels, 30 mCi of oxygen-IS-labeled
carbon monoxide (CI50 ) was administered by inhalation to
label the blood pool, permitting correction for intravascular
tracer consistent with a method previously developed and
validated in our laboratory (8). Flow in ischemic zones was
expressed in terms of flow as a fraction of flow in normal
regions.
Approximately 10 minutes later, when activity from CI50
had decayed to near background levels, a bolus of 25 to 35
mCi of "C-palmitate was injected intravenously. Ten con-
secutive images over intervals of 2 minutes each were col-
Table 1. Heart Rate and Mean Arterial Pressure after Coronary Occlusion and
After Reperfusion
Ischemia for I hour
Heart rate (beats/min)
Mean arterial pressure (mm Hg)
Ischemia for 2 hours
Heart rate (beats/min)
Mean arterial pressure (mm Hg)
Reperfusion for I hour
Heart rate (beats/min)
Mean arterial pressure (mm Hg)
Control (n = IS)
102 ± 25
137 ± 5
98 ± 40
144 ± 5
Reperfusion
Alone (n = 13)
104 ± 13
120 ± 19
95 ± 18
119 ± 14
138 ± 46
118 ± 10
Reperfusion Plus
Diltiazem (n = 13)
105 ± 24
116 ± 21
106 ± 15
us ± 21
123 ± 51
110 ± 15
Values are means ± SD. n = number of dogs.
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lected beginning with the time of injection. In animals given
streptokinase, tomography was repeated I hour after reper-
fusion.
For analysis of blood flow or distribution of palmitate,
I crrr' transmural regions of interest were selected from
normal septal, posterior and posterolateral regions of the
left ventricle and from anterolateral, anterior and antero-
septal ischemic zones. Identical regions of interest were
analyzed in both H2 150 and ltC-palmitate tomograms.
Isocount contours representing 50% ofpeak myocardial
counts were constructed. The percent of myocardium sub-
jected to reduced perfusion was defined as the region at risk,
and the percent exhibiting reduced metabolism was defined
as the region of injury. Regions exhibiting reduced uptake
of palmitate under these conditions correlate closely with
zones of infarction that are identifiable histologically and
enzymatically (9).
Statistical analysis. Dogs exhibit considerable variation
of infarct size in response to occlusion of the left anterior
descending coronary artery and in response to interventions
designed to limit infarct size. Accordingly, we employed
nonparametric tests for analysis of differences (10). Com-
parisons between groups were made with the Mann-Whitney
U test. Sequential measurements within a group were com-
Table 2. Myocardial Blood Flow (mllmin per g) Determined With Radiolabeled
Microspheres in 41 Dogs
Ischemia (for 2 hours)
Lateral ischemic
Endocardium
Epicardium
Central ischemic
Endocardium
Epicardium
Septal ischemic
Endocardium
Epicardium
Posterior normal
Endocardium
Epicardium
Reperfusion (for I hour)
Lateral ischemic
Endocardium
Epicardium
Central ischemic
Endocardium
Epicardium
Septal ischemic
Endocardium
Epicardium
Posterior normal
Endocardium
Epicardium
Reperfusion (for 22 hours)
Lateral ischemic
Endocardium
Epicardium
Central ischemic
Endocardium
Epicardium
Septal ischemic
Endocardium
Epicardium
Posterior normal
Endocardium
Epicardium
Control (n = 15)
0.15±0.19
0.14 ± 0.14
0.08 ± 0.09
0.13 ± 0.08
0.16 ± 0.18
0.21 ± 0.19
1.04 ± 0.62
0.97 ± 0.61
0.03 ± 0.05
0.08 ± 0.05
0.03 ± 0.Q3
0.13±0.14
0.04 ± 0.06
0.06 ± 0.05
0.73 ± 0.48
0.67 ± 0.45
Reperfusion Reperfusion Plus
Alone (n = 13) Diltiazem (n = 13)
0.17 ± 0.23 0.09 ± 0.08
0.18 ± 0.21 0.15 ± 0.08
0.06 ± 0.05 0.07 ± 0.07
0.20 ± 0.14 0.12 ± 0.06
0.10 ± 0.11 0.13 ± 0.09
0.23 ± 0.15 0.17 ± 0.11
0.83 ± 0.07 0.93 ± 0.53
0.78 ± 0.18 0.84 ± 0.55
0.65 ± 0.29 0.74 ± 0.40
1.03 ± 0.31 0.83 ± 0.43
1.02 ± 0.59 0.66 ± 0.33
1.16 ± 0.42 0.81 ± 0.38
0.90 ± 0.51 0.81 ± 0.43
0.97 ± 0.39 0.89 ± 0.47
0.91 ± 0.29 1.13 ± 0.88
0.86 ± 0.31 1.16 ± 0.97
0.33 ± 0.19* 0.54 ± 0.40*
0.53 ± 0.20* 0.70 ± 0.29*
0.44 ± 0.28* 0.45 ± 0.23*
0.61 ± 0.31* 0.62 ± 0.27*
0.53 ± 0.36* 0.53 ± 0.14*
0.57 ± 0.26* 0.65 ± 0.25*
0.90 ± 0.12 1.15 ± 0.21
0.90±0.ll 1.08 ± 0.37
Values are means ± SD for endocardial and epicardial halves of transmural sections. *Values significantly
different from those in the control group (p < 0.05).
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pared with the Wilcoxon signed rank test. Differences at
the 5% level were considered to be significant.
Results
Persistent occlusion of the left anterior descending coro-
nary artery after 24 hours was documented in all 15 control
dogs. In all 26 dogs subjected to reperfusion, intracoronary
streptokinase restored patency of the left anterior descending
coronary artery and its branches. Repeat angiography im-
mediately before termination of the study documented the
persistence of patency in all but one animal (excluded from
subsequent analysis).
Mean arterial pressures and heart rates were similar in
the three groups throughout the interval of ischemia as
shown in Table J. Infusion of diltiazem did not significantly
alter heart rate or blood pressure before reperfusion as shown
Figure 1. Transverse reconstructed tomograms from a single
plane through the middle of the left ventricle of a control dog after
coronary occlusion. All images have been corrected for vascular
activity with the use of blood pool images obtained at each interval
after inhalation of oxygen-IS-labeled carbon monoxide. In this
and all subsequent tomograms, anterior myocardium is depicted
at the top, posterior at the bottom, lateral wall on the left and
interventricular septum on the right. A and B illustrate perfusion
images obtained after injection of oxygen-IS-labeled water. C and
D depict the distribution of carbon-ll-labeled palmitate. Tomo-
grams shown in A and C were obtained 90 minutes after occlusion
of the left anterior descending coronary artery, and tomograms in
panels Band D were obtained 24 hours after occlusion. A large
flow defect is observed in the anterior region supplied by the
occluded artery, with a corresponding diminution of uptake of IIC_
palmitate. In this example from a dog with persistent occlusion,
perfusion and palmitate uptake remained consistent over 24 hours.
In this transverse slice, the discontinuity of tracer uptake in the
posterior myocardium is due to the mitral valve apparatus. The
20 grade linear color scale indicates counts per pixel with the peak
counts per pixel indicated at the white grade.
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Figure2. Transverse reconstructed tomograms from adog given
streptokinase alone after coronary occlusion, depicting perfusion
(A, D, C) and uptake of carbon-II-labeled palmitate (D, E, F).
Tomograms in A and D were obtained 90 minutes after coronary
occlusion; those inDand E were obtained I hour after reperfusion
and those inC and F were obtained 22 hours after reperfusion (24
hours after occlusion). Perfusion was not different from normal 1
hour after thrombolysis, but was markedly diminished at 24hours
despite maintained macrovascular patency documented angio-
graphically. Uptake of palmitate was restored only partially 1hour
after reperfusion. Restoration was similar at 24 hours.
by the similarity of values I and 2 hours after occlusion.
Administration of streptokinase was associated with signif-
icantly higher heart rates as a result of arrhythmias accom-
panying reperfusion. There was, however, no difference
with respect to heart rate or mean arterial pressure in the
two groups subjected to reperfusion, that is, dogs that had
and dogs that had not been given diltiazem.
Effects on regional myocardial blood flow (Table 2).
The extent of ischemia was similar in each of the three
groups, with transmural flows in the anterior ischemic zone
averaging 0.14 ± 0.14, 0.16 ± 0.15 and 0.12 ± 0.09
mllmin per g for dogs with occlusion alone, those with
reperfusion alone and those with reperfusionplus diltiazem,
respectively.
Thrombolysis restored flow in ischemic zones to near
normal (1.02 mllmin per g) levels. Transmural blood flow
in the previously ischemic anterior region I hour after re-
perfusion was not statisticallydifferent in dogs subjected to
reperfusion whether or not they were also treated with dil-
tiazem (0.94 ± 0.42 mllg per min in dogs with reperfusion
alone compared with 0.83 ± 0.43 mllmin per g for those
with diltiazem).
Despite restoration of perfusion early after thrombolysis
and maintenance of macrovascular patency 24 hours after
occlusion, flow in reperfused regions at 24 hours was sig-
nificantly lower than flow in normal regions, averaging
0.50 ± 0.26 ml/g per min in dogs with reperfusion alone
and 0.58 ± 0.26 mllmin per g in dogs with reperfusion
plus diltiazem (normal flow = 1.01). Nevertheless, per-
fusion in both groups was significantly greater than that in
dogs with persistent occlusion (0.07 ± 0.08 ml/min per g).
Effects on myocardial creatine kinase depletion. In-
farct extent was determined at necropsy by analysis of myo-
cardial creatine kinase depletion in 10 control dogs with
occlusion alone, 8 dogs with reperfusion alone and 9 dogs
with reperfusionand diltiazem. Infarctextent averaged29.9
g or 27.9 ± 11.4% of left ventricular weight judging from
creatine kinase depletion from hearts in dogs with persistent
occlusion. Thrombolysis alone reduced the extent to 18.1
g or 16.7 ± 10.1% of left ventricular weight (p < 0.05).
Thrombolysis combined with diltiazem further reduced the
infarct extent to 8.4 g or 9.4 ± 6.7% of left ventricular
weight (p < 0.05, compared with results after reperfusion
alone), reflecting an additional44% decrease of infarct size
compared with the reduction induced by reperfusion alone.
Results with positron tomography. Sixteen dogs were
evaluated by positron emission tomography including six
control dogs with persistent occlusion, fi ve given strepto-
kinase alone and five given streptokinase and diltiazem.
Because the tomograph used does not permit gating needed
to correct for cardiac motion, absolute quantification of the
myocardial distribution of radioactivity was not possible.
Accordingly , results wereexpressedas relativeactivity, that
is, the ratioof activity in the anteriormyocardium subtended
by the left anterior descending coronary artery compared
with that in normal myocardium.
Relative myocardial blood flow was assessed by analysis
of H2150 content in a region of myocardium corrected for
activity in the blood pool. In control dogs with occlusion
alone. no increase in relative blood flow to the ischemic
zone was evident 24 hours after occlusion as illustrated by
the tomograms in Figure I. Coronary thrombolysis induced
with streptokinase resulted in substantial restoration of flow
in the previously ischemic anterior region (Fig. 2). Similar
increases were evident when treatment with diltiazem was
implemented 90 minutesafter occlusionfollowed by throm-
bolysis with streptokinase (Fig. 3). Twenty-four hours after
occlusion, flow was diminished compared with its initial
augmentation in zones subjected to reperfusion although
flow still exceeded that evident before reperfusion (Fig. 2).
The same phenomenon was seen despite administration of
diltiazem (Fig. 3). Flows in the center of ischemic zones
are summarized in Figure 4. Relative flow measurements
obtained by positron emission tomography correlated with
determinations of flow based on analysis of the distribution
of radiolabeled microspheres measured directly (Fig. 5).
Uptake of lie-palmitate in ischemic myocardium soon
after reperfusion and in myocardium subjected to reperfu -
sion for 22 hours, that is, 24 hours after occlusion, is sum-
marized in Figure 4. Sequential tomogramsobtained during
the interval from 6 to 12 minutes after intravenous admin-
istration of IIC-palmitate and corrected for IIC-palmitate
activity in the blood pool are shown in Figures 1 through
3. Uptake of "Cvpalmitate in control dogs with occlusion
alone was diminished after the onset of ischemia and sim-
ilarly diminished24 hours after occlusion. Reperfusion par-
tially restoreduptakeof IIC-palmitate in the previouslyisch-
emic region, but a residual region of decreased uptake
persisted. Twenty-four hours after occlusion, uptake of llC_
palmitate in dogs subjected to reperfusion was significantly
greater than that in control dogs with persistent occlusion
although uptake had diminished modestly in comparison
with that 1 hour after reperfusion. In dogs given diltiazem
as well as streptokinase, uptake of IIC-palmitate was 33%
greater than that in previouslyischemiczones in comparison
with values in dogs subjected to reperfusion alone.
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Figure 4. Tomographically delineated H2 1sO (top) and IIC-pal_
mitate (bottom) expressed as the ratio between values in anterior,
previously ischemic myocardiumand normal tissue obtained in six
control dogs, five dogs subjected to reperfusion alone and five
dogs subjected to reperfusion plus diltiazem. Values represent
means ± SD.
Figure 3. Transverse reconstructed tomogramsfrom a dog given
intravenousdiItiazem before induction of thrombolysis with strep-
tokinase. Perfusion is depicted in A, Band C. The distribution of
carbon-II-labeled palmitate is shown in D, E and F. Time points
are the same as those in Figure 3; conditions were: A and D,
occlusion; Band E, I hour after thrombolysis; C and F, 22 hours
after reperfusion. Perfusion was diminished at 24 hours compared
with its early augmentation just as in dogs given streptokinase
alone. However, uptake of palmitate is improved compared with
the restoration in dogs given streptokinase alone, with substantial
improvement evident at 24 hours.
Regions at risk assessed from perfusion images obtained
after occlusion and before reperfusion, and zones of in-
farction estimated from the palmitate images obtained 24
hours after occlusion are summarized in Table 3. Regions
at risk constituted 20.6 to 40.0% of the left ventricle. Values
were similar among the three groups of dogs studied.
Tomographically estimated infarct size was reduced by
an average of 43% by reperfusion alone. It was reduced
slightly more in animals given diltiazem as well as strep-
tokinase. Expressed as a percent of the region at risk, re-
perfusion alone decreased tomographically estimated infarct
size by 50%. Administration of diltiazem followed by re-
perfusion decreased tomographically estimated infarct size
by 51% more than the reduction elicited by reperfusion
alone. Because of the small sample size, however, this
additional 50% reduction was not statistically significant.
Combined results. When results obtained by direct mea-
surement in myocardium and those obtained from tomo-
89.6 ± 11.4
(75.8 to 102.3)
45.1 ± 29.8*
(11.9 to 78.7)
22.3 ± 16.4*
(3.6 to 58.3)
Infarct Size
(% region at risk)
•
y. 0.856, - 0.01
r· 0.94
30.6 ± 7.3
(20.6 to 38.6)
31.8 ± 4.5
(26.0 to 35.8)
30.5 ± 11.6
(29.4 to 40.0)
Region at Risk
(% left ventricular mass)
0.2 0.4 0.6 0.8 1.0
RElATIVE MBF - MICROSPHERES
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0
'" 0.8-N
1:
u..
CO 0.6:E •
w
> •~. 0.4
••
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W ••
'" ••0.2 • • • •
•
.
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• • •
Reperfusion
alone (n = 5)
Reperfusion plus
diltiazem (n = 5)
Control (n = 6)
Values are means ± SO. Values in parentheses represent range of
values for each group. Region at risk was determined as the percent of
left ventricle exhibiting less than 50% of maximal H2 ' 50 content after
coronary occlusion. Infarct extent was measured as the percent of left
ventricle with less than 50% of maximal llC-palmitate uptake 24 hours
after occlusion and expressed as the percent of the region at risk. *Values
significantly different from control values, p < 0.05.
Discussion
The results of this study indicate that administration of
diltiazem before thrombolysis increases salvage of myo-
cardium compared with salvage achieved by thrombolysis
alone.
Methodologic considerations. This study was under-
taken to evaluate preservation of myocardium by pharma-
cologic agents under conditions avoiding thoracotomy for
several reasons. Even with chronically instrumented prep-
Table 3. Extent of Region at Risk and Infarct Size
Determined Tomographically in 16 Dogs
graphic assessments before death were combined, the con-
sistency of changes observed with both was evident (Fig.
6). Thrombolysis reduced infarct size from 27.3 ± 9.2 to
17.1 ± 8.7% of left ventricular weight (p < 0.05). Throm-
bolysis coupled with administration of diltiazem further re-
duced the infarct extent to 9.3 ± 6.2% (p < 0.05, compared
with results with reperfusion alone).
Figure 5. Correspondence between measurements of relative
(anterior/normal) myocardial blood flow (MBF) obtained tomo-
graphically (H2ISO) and those acquired with radiolabeled micro-
spheres. Althoughflowis underestimatedslightlyby positronemis-
sion tomography, the correspondence between results obtained
with the two types of determinations is close.
24 hr
c:::J Control
~ Reperfusion Alone
_ Reperfusion Diltiazem
Treated
1hr
Reperfusion
1hr
Reperfusion
0 1.0
10
-N 0.8J:>-t-
w> 0.6
>-
_t- 0.4~u
...J<l: 0.2w
0:::
W
~ 1.0
~ 0.8
...J>-~!:: 0.6
,>u_
0.4~t-
~~ 0.2
~
...J
W
0:::
870 KNABB ET AL.
MYOCARDIAL SALVAGEBY D1LTlAZEM
lACC Vol. 8. No. 4
October 1986:861-71
30
~
;e
- 20
u.J
N
Vi
I-
U
a<
~ 10
~
Control Reperlusion Repeefvsice
Al one Dihioloem
Ieec ted
Figure 6. Pooled results of the extent of infarction, expressed
as the percentage of left ventricular mass based on tomographic
determinations of infarct size and direct measurement of myo-
cardial creatine kinase depletion (n = 15 control dogs, 13 with
reperfusion alone and 13 with reperfusion plus diltiazem). Values
represent means ± SD. *Values significantly different from con-
trols; **Values significantly different from those with reperfusion
alone, p < 0.05 for both.
arations, effects of isolation and instrumentation of the coro-
nary artery may lead to induction of collateral circulation
(11). Acute closed chest occlusion of a coronary artery under
fluoroscopic techniques such as those used in the present
study avoids these problems but requires the use of anes-
thesia. Although blood flow in the central ischemic zones
of conscious, chronically instrumented dogs may exceed
that in acute occlusion in open chest dogs (12), it is not
clear whether the difference reflects induction of collateral
circulation or the absence of anesthesia . Blood flow to the
central ischemic zones in our study was consistently less
than that reported in chronically instrumented dogs.
One disadvantage of eliciting reperfusion with a throm-
bolytic agent is that the timing of reperfusion cannot be as
well controlled as it can by reflow induced by ligature release
in open chest or chronically instrumented preparations. This
may result in some variability in the duration of ischemia
before reperfusion and therefore in infarct size. In our study,
the onset of reperfusion , indicated by the onset of reper-
fusion arrhythmia, occurred within 30 minutes of initiation
of streptokinase infusion in most dogs and always within I
hour. Induction of reperfusion by dissolution of an occlusive
thrombus was employed in part because of parallels to clin-
ically induced reperfusion.
Tomographic assessments of perfusion with H2150 have
been shown to correlate closely with determinations of flow
with radiolabeled microspheres (8,13) . In previous studies ,
infarct extent expressed as the percent of left ventricular
myocardium that accumulates less than 50% of lIC_pal_
mitate compared with that accumulated by normal myocar-
dium was found to correlate with direct determinations of
infarct size based on measurement of myocardial creatine
kinase depletion and histologic study (9).
Determinations of regions at risk and of infarct extent
by positron emission tomography are influenced by spatial
limitations inherent in tomographic imaging, including ef-
fects of cardiac motion, partial volume effects and spillover
of radioactivity (14-17). Despite these limitations, positron
emission tomography exhibits several advantages compared
with single photon imaging . Furthermore, assessment of
regions at risk with H2 150 and delineation of infarct zones
with "C-palmitate are subject to the same limitations in
each group of dogs. Because positron emission tomography
is noninvasive , it can be applied conveniently and safely in
clinical investigations.
Enhanced salvage of myocardium by diltiazem. Dil-
tiazem administered before thrombolysis resulted in a re-
duction of infarct size by 66% compared with values in dogs
with persistent occlusion and a similar reduction of flow
after coronary occlusion . The infarct extent was 46% less
than that in dogs subjected to reperfusion alone without
concomitant diltiazem (p < 0.05).
Calcium channel entry blockers appear to enhance re-
covery of ventricular performance associated with reper-
fusion (2). They appear to favorably alter the balance be-
tween myocardial oxygen supply and demand by improving
myocardial perfusion in some circumstances, decreasing ox-
ygen consumption of ischemic myocardium, or both. Ni-
fedipine, given 30 minutes after the onset of ischemia, in-
creases collateral blood flow in dogs and reduces myocardial
creatine kinase depletion (18). Treatment with diltiazem
maintains myocardial cellular integrity and adenosine tri-
phosphate (ATP) stores and reduces accumulation of lactate
and free fatty acids (19) . It also improves the function of
hypokineti c segments of ischemic myocardium (20). Both
verapamil and diltiazem appear to protect myocardium when
given before ischemia (21-23). Diltiazem alone or in com-
bination with propranolol has been reported to enhance per-
formance of reperfused myocardium (2,3). We elected to
admini ster diltiazem 90 minutes after occlusion and 30 min-
utes before initiation of thrombolysis to determine whether
effects of diltiazem on reperfusion injury could be differ-
entiated from effects on injury resulting from ischemia alone.
Calcium channel entry blockers may decre ase injury in
ischemic myocardium subjected to reperfusion by inhibiting
the rapid influx of calcium seen otherwise and implicated
as being deleterious to cell membranes and mitochondria.
They decrease the accumulation of calcium precipitates in
mitochondria isolated from such tissue (24). Furthermore,
they may decrease the extent of generation of potentially
toxic oxygen free radicals by preventing conversion of xan-
thine dehydrogenase to xanthine oxidase (25,26).
Effects of dlltiazem on myocardial perfusion after
thrombolysis. Because calcium channel entry blockers are
vasodilators , they may increase coronary collateral flow and
blunt the "no reflew" phenomenon otherwise seen after
reperfusion . In our study, however, beneficial effects of
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diltiazem appeared to be independent of direct effects on
myocardial perfusion, judging from the comparable resto-
ration of perfusion measured 1 hour and 22 hours after
thrombolysis induced by streptokinase in dogs with or with-
out concomitant diltiazem. Flow to the endocardium in the
centrally ischemic zones was affected most severely in both
groups, but flow was diminished to some extent throughout
the ischemic zone. The reduction of flow in reperfused myo-
cardium 24 hours after coronary occlusion is consistent with
results of other researchers, Higginson et al. (27) reported
that despite initial restoration of flow to normal by reper-
fusion after 2 hours of ischemia, flow was less than 0.2
mllmin per g 24 hours later. The late "no-reflew" phe-
nomenon may have been less severe in our study because
of the richer collateral supply to myocardium in the anterior
wall compared with collateral supply to the posterior pap-
illary muscles evaluated by Higginson et al. (27), In ad-
dition, physiologic stress associated with thoracotomy in
the Higginson study may have exacerbated the "no reflow"
phenomenon.
Clinical implications. Results of this study suggest that
diltiazem enhances salvage of myocardium subjected to re-
perfusion. They demonstrate the feasibility of utilizing pos-
itron emission tomography with tracers of flow and metab-
olism for assessment of adjunctive pharmacologic agents in
the setting of clinical coronary thrombolysis. The results
also suggest that calcium channel entry blockers are prom-
ising for enhancement of salvage of myocardium and that
they merit exploration in patients subjected to coronary
thrombolysis.
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